跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salofalk - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salofalk
Approved
STANDARD
Salofalk
Losan Pharma GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7b052223ecf89617
Company
Losan Pharma GmbH
Type
Standard
Approval Details
Approval Id
7b052223ecf89617
Drug Approval Philippines Name
Salofalk
Product Name
Salofalk
Registration Number
DR-XY21352
Brand Name
Salofalk
Generic Name
Mesalazine
Dosage Form
Gastro-Resistant Tablet
Dosage Strength
500 mg
Manufacturer
Losan Pharma GmbH
Importer
A. Menarini Philippines, Inc.
Distributor
A. Menarini Philippines, Inc.
Company Detail Path
/organization/losan-pharma-gmbh
Issuance Date
24 February 2025
Expiry Date
24 February 2030
Pharmacologic Category
Intestinal Anti-inflammatory Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7b052223ecf89617
Type
Standard
Back to Philippines FDA Approvals